Sana Biotechnology, Inc.

Sana Biotechnology, Inc.

Sana Biotechnology, Inc.

Overview
Headquarters

188 East Blaine Street, Suite 400, Seattle, WA, 98102, USA

Type of Company

Public

Employees (Worldwide)

101 - 250

Industries

Biotechnology
Hospitals & Patient Services

Company Description

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses in identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 13, 2018 and is headquartered in Seattle, WA.

Contact Data
Trying to get in touch with decision makers at Sana Biotechnology, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer

Secretary, Executive Vice President & General Counsel

Chief Technology Officer & Senior Vice President

Chief People Officer & Executive Vice President

Executive Vice President & Chief Business Officer

Head of Corporate Operations

Executive Vice President & Head of Technical Operations

Head of Sanax

Senior Vice President & Head of CNS Therapy

Board of Directors

Chief Executive Officer at GRAIL, Inc.

Director of the Harvard Gene Therapy Initiative at Harvard University - Harvard Medical School

Chairman & Chief Executive Officer at Russell Investments Implementation Services LLC

Co-Founder at Vir Biotechnology, Inc.

Former Chairman & Chief Executive Officer at Frontier Communications Corp.

Co-Founder at Indigo Ag, Inc.

Former Senior Vice President & Head of Global Clinical Development in Research & Development at Merck KGaA

Chief Executive Officer at Patrick Y. Yang LLC

President & Chief Executive Officer at Sana Biotechnology, Inc.

Managing Partner at Flagship Pioneering

Paths to Sana Biotechnology, Inc.
Potential Connections via
Relationship Science
You
Sana Biotechnology, Inc.
Recent Transactions
Details Hidden

Sana Biotechnology, Inc. issued USD Common Stock

Details Hidden

Sana Biotechnology, Inc. raised money in a private placement transaction

Details Hidden

Sana Biotechnology, Inc. raised money in a private placement transaction

Transaction Advisors
Escrow Agent

Advised onSana Biotechnology, Inc. issued USD Common Stock

Underwriter

Advised onSana Biotechnology, Inc. issued USD Common Stock

Underwriter

Advised onSana Biotechnology, Inc. issued USD Common Stock

Legal Advisor

Advised onSana Biotechnology, Inc. issued USD Common Stock

Counsel

Advised onSana Biotechnology, Inc. issued USD Common Stock

Associate

Advised onSana Biotechnology, Inc. issued USD Common Stock

Key Stats and Financials As of 2020
Market Capitalization
$4.03B
Total Enterprise Value
Earnings Per Share
$-1.52
Revenue
$0
Net Profit
$-285M
EBITDA
$-151M
Total Debt
$71.9M
Total Equity
$432M
Investors
Details Hidden

Investor at Applied Intuition, Inc.

Details Hidden

Chairman & Co-Founder at Moderna, Inc.

Details Hidden

Co-Founder at Vir Biotechnology, Inc.

Suppliers
Harvard University Schools & Student Services | Cambridge, MA

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

University of Washington Power & Utilities | Seattle, WA

Founded in 1861 by a private gift of 10 acres in what is now the heart of downtown Seattle, the UW is one of the oldest public universities on the West Coast. We’re deeply committed to upholding the responsibility that comes with that legacy. And being public has always meant being accessible. Anyone can enjoy and be enriched by all the UW has to offer, including world-class libraries, art, music, drama, sports and the highest quality medical care in Washington state. Being public also means being engaged with our communities, and through knowledge and discovery we are elevating the quality of lives of others.

University of California Holding Companies | Oakland, CA

The University is governed by The Regents, which under Article IX, Section 9 of the California Constitution has "full powers of organization and governance" subject only to very specific areas of legislative control. The article states that "the university shall be entirely independent of all political and sectarian influence and kept free therefrom in the appointment of its Regents and in the administration of its affairs." Board Membership Article IX, Section 9 was drafted in 1878 after a decade of political conflict demonstrated the importance of sheltering the university from shifting political winds. The board consists of 26 members: 18 regents are appointed by the governor for 12-year terms One is a student appointed by the Regents to a one-year term Seven are ex officio members -- the Governor, Lieutenant Governor, Speaker of the Assembly, Superintendent of Public Instruction, president and vice president of the Alumni Associations of UC and the UC president. In addition, two faculty members -- the chair and vice chair of the Academic Council -- sit on the board as non-voting members. Board Officers The Governor is officially the president of the Board of Regents; however, in practice the presiding officer of the Regents is the Chairman of the Board, elected from among its body for a one-year term, beginning July 1. The current Chairman is Regent Sherry Lansing. The Vice Chairman is Regent Bruce Varner. The Regents appoints Officers of The Regents: the General Counsel; the Chief Investment Officer; the Secretary and Chief of Staff; and the Chief Compliance and Audit Officer. Former Regents Here is a list of individuals who have served as Regents of the University of California: Former Regents Committees and Meetings The Regents operates through 10 standing committees: Compliance and Audit, Compensation, Educational Policy, Finance, Governance, Grounds and Buildings, Health Services, Investments, Long Range Planning, and Oversight of the Department of Energy Laboratories. The Regents meets six times a year every other month in two-day meetings

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Bristol-Myers Squibb Company Pharmaceuticals - New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Gilead Sciences, Inc. Biotechnology - Foster City, CA

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sana Biotechnology, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sana Biotechnology, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Sana Biotechnology, Inc..